Enjoy complimentary customisation on priority with our Enterprise License!
The global microfluidics market for healthcare applications is anticipated to reach a value of USD 110.2 billion, with a notable compound annual growth rate (CAGR) of 27.16% during the period spanning from 2023 to 2028. The market is experiencing significant growth, driven by the compact size of microfluidic devices, which enables portability and ease of use in various healthcare settings. Another trend is the increasing use of paper-based microfluidic devices and in-vitro diagnostics, offering advantages such as cost-effectiveness, drug delivery services, simplicity, and biocompatibility. Furthermore, the ability to manipulate and observe properties of fluids at the microscopic level has led to advancements in diagnostics, drug discovery, and bioprocessing. These factors, coupled with the potential for automation and integration with other technologies, are propelling the microfluidics for healthcare application market forward. However, challenges such as scalability, compatibility with various biological samples, and regulatory approval processes remain to be addressed. Despite these challenges, the market is expected to continue expanding due to its potential to revolutionize healthcare through miniaturized, cost-effective, and efficient solutions.
For further insights into this report, please proceed to download a sample of the report.
The in-vitro diagnostics sector achieved a valuation of USD 9.60 billion in 2018 and experienced continuous growth until 2022. The market share of the in-vitro diagnostics segment is expected to exhibit substantial expansion throughout the projected timeframe. In-vitro diagnostics holds a prominent position within the realm of microfluidic healthcare applications. The potential of microfluidics for medical device manufacturers and diagnostics is substantial. Microfluidic diagnostic kits capitalize on compact integrated systems to achieve quick turnaround times, delivering instant outcomes and minimizing expenses. Its implementation has facilitated regular health monitoring for both medical practitioners and patients, resulting in significant market investment due to these notable benefits.
To obtain additional information regarding other sections, please download a sample report.
Large companies are interested in In-vitro diagnostics technology and are investing in or acquiring smaller companies in this space. Such factors are anticipated to drive the growth of the in-vitro diagnostics segment of the microfluidics market for healthcare applications during the forecast period.
To comprehend geographical patterns, it is recommended to download a sample of the report.
The market in North America occupies a significant position- It is projected that North America will account for 40% of the global market growth in the foreseeable future. The presence of numerous medical device manufacturers in the region contributes to the expansion of the microfluidics market for healthcare applications in North America. Key players in this region include Baxter, Beckman Coulter, BD, Boston Scientific, GENERAL ELECTRIC, Johnson and Johnson Services, Medtronic, St. Jude and Stryker, are expanding their financial commitment toward the development and distribution of a wide variety of medical devices that Technavio anticipates will incorporate a significant array of microfluidic devices.
The demand for medical devices in North America is further increase by the growing need for such devices in the region. The United States, being the largest market and a significant exporter of medical devices, plays a crucial role in driving the market in this region. In 2020, the market value of medical devices in the United States was around USD 176 billion, making it one of the most profitable markets globally in terms of sales. Forecasts suggest that the United States will maintain its position as the global leader in the medical devices market in the coming years. The rising elderly population in the United States, coupled with heightened healthcare expenditures by the US government towards research and development in the medical field, are the primary drivers of the demand for medical devices in both domestic and international markets. This is anticipated to drive the expansion of the targeted market in North America during the forecast period.
Microfluidics is a rapidly growing field in healthcare applications, utilizing technologies such as soft lithography to create micro-engineered devices. These devices have a significant impact in life sciences and medical research, particularly in areas like drug discovery, insulin pumps for glucose level management, and infection detection. Microfluidics plays a crucial role in analyzing biological samples at the molecular level, including vascular endothelium studies using PCR technique and genome analysis through Microfluidic Chips. Cepheid's automated microfluidic polymerase chain reaction (PCR) is an alternate system employed for the swift screening and diagnosis of methicillin-resistant Staphylococcus aureus (MRSA) infections in hospital settings. Microfluidics devices are fabricated from various materials such as glass, silicon, and polymers, and are used in Drug Delivery Systems, Capillary Electrophoresis, and Micro Dispensing. The market for microfluidics in healthcare is vast and diverse, with applications in clinical diagnostics and research. Key technologies include microneedles for painless injections and microfluidic devices for precise drug delivery. The market for microfluidics in healthcare is expected to grow significantly due to its ability to provide accurate, cost-effective, and efficient solutions for various healthcare applications.
The compact size of microfluidic devices is notably driving the microfluidic market for healthcare application growth. Microfluidic devices are compact and use fewer reagents, resulting in lower costs and less medical waste. The large surface area-to-volume ratio and low thermal mass of these devices facilitate precise temperature control, rapid heat transfer, and rapid adaptation to temperature changes. Due to the small size of microfluidic devices, the rapid diffusion of liquids improves the accuracy and speed of reactions. This improves the performance of microfluidic assays, shortens measurement times, and increases assay sensitivity.
For example, microfluidic devices can help reduce dispersion broadening in electrophoretic separations by rapidly dissipating Joule heat. Shortening the measurement time reduces peak broadening and thus improves sensitivity for some separations. Also, microfluidic devices are used to recycle fluid temperature by forcing the fluid to flow through different chip regions at different temperatures. Such factors are anticipated to drive the growth of the microfluidics market for healthcare applications during the forecast period.
The use of paper-based microfluidic devices is a key trend influencing the microfluidic market for healthcare application growth. Paper-based microfluidic devices use hydrophobic channel walls printed on paper. These hydrophobic walls ensure controlled velocity and direction of liquid flow. Using paper in the manufacture of such devices greatly reduces the cost of these devices and simplifies their disposal. In 2020, paper-based technology was limited to simple design devices. However, the fabrication of microfluidic devices from paper technology is expected to have a significant impact on the microfluidic market during the forecast period. One of the first steps in the treatment of any disease is to perform a diagnostic analysis of the patient. There are several disease-detection devices and instruments on the market, but they are very expensive.
Additionally, these devices and equipment require trained professionals to operate, further increasing costs. To overcome these problems, researchers are focusing on developing paper-based microfluidic devices. In this process, the substrate for generating microfluids consists of paper. Paper microfluidic devices are inexpensive and environmental friendly. Therefore, these devices are in great demand in both developed and developing countries. Another key feature making paper microfluidics a major trend in the global microfluidics market for healthcare applications is the ability to instantly perform multiple medical tests using chips. This can be done when there is an urgent need or in remote areas where basic facilities such as electricity are not available to power medical equipment. All these factors make them highly attractive and are likely to drive the growth of the market.
The changes in the properties of fluids at the microscopic level are challenging the microfluidic market for healthcare application growth. Microfluidics tend to change their physical properties at the microscopic level. A fluid behaves very differently at the micro-scale compared to using the same fluid at the macro scale. At a smaller level, features such as surface tension, fluid resistance, and energy dissipation come to the fore. The Reynolds number compares the effect of the momentum of a liquid to the effect of its viscosity. At the micron level, the Reynolds number becomes very low, and the flow becomes laminar instead of turbulent. In laminar flow, liquids mix only by diffusion processes. Diffusion is a rather slow mechanism that makes reactions in microfluidic devices more difficult to achieve. As a result, measurement errors can occur that can lead to erroneous readings in multiple medical tests.
Further, another important property to consider in drug testing is slip resistance. At the micro level, no slip occurs between liquids and solids. Liquid molecules adhere to a solid surface and the liquid moves against it. This indicates that the bottom remains stationary while the top of the liquid moves at the same speed. This leads to the formation of shear stress, an important factor to consider in drug testing. Shear stress should be considered when designing microfluidic chips, as increased shear stress indicates a lack of flow, thereby limiting the study of cell interactions. Therefore, shear stress must be modeled or calculated when designing microfluidic devices such as chips. Such factors are expected to hinder the growth of the microfluidics market for healthcare applications during the forecast period.
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market growth and trends report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments
The microfluidics market is a significant and growing sector in the healthcare industry, driven by advancements in Soft lithography technology. This technology plays a crucial role in various applications in Life sciences, Medical research, and Drug discovery. Microfluidics devices are used in Insulin pumps and Intelligent medications, such as Subcutaneous patches, for precise dosage delivery. Commercialization of microfluidics technology in the Environment industry is also on the rise, with applications in Molecular biology, microfluidic devices, PoC diagnostics, and PCR systems. Hospitals and Diagnostic centers are increasingly adopting microfluidics devices for Genomics technologies, including Viral load testing, Antigens detection, and Glucose levels measurement. Infection detection is another major application area, with Microfluidics devices used for detecting pathogens in various samples. The technology is also used in Vascular endothelium studies, PCR technique, and Genome analysis. Microfluidics devices are made using various materials, including Glass, Silicon, and Polymers. Advanced technologies like Nanopore technologies, Immunoassays, Opto Reader, Organs on chip, Cluster Well chip, High precision PCR, Microfluidic Chips, and Microneedles are also gaining popularity in the market. Overall, the Microfluidics market is expected to grow significantly in the coming years due to its potential in various healthcare applications.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
183 |
|
Base year |
2023 |
|
Historic period |
2018 - 2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 27.16% |
|
Market growth 2024-2028 |
USD 110.2 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
20.89 |
|
Regional analysis |
North America, Europe, APAC, South America, and Middle East and Africa |
|
Performing market contribution |
North America at 40% |
|
Key countries |
US, China, Germany, UK, and Japan |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
908 Devices Inc., Agilent Technologies Inc., BioMerieux SA, Bio Rad Laboratories Inc., Blacktrace Holdings Ltd., Cellix Ltd., Danaher Corp., Elveflow, Fluigent SA, General Electric Co., Hamilton Co., Illumina Inc., Microfluidic Chipshop GmbH, MICRUX FLUIDIC S.L., Perkin Elmer Inc., QIAGEN NV, SMC Corp., Teledyne Technologies Inc., Thermo Fisher Scientific Inc., and uFluidix Inc. |
|
Market dynamics |
Parent market analysis, Market forecasting , market forecast, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, Market growth and Forecasting, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Material
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.